Literature DB >> 8901453

Primary cultures of cardiac muscle cells as models for investigation of protein glycosylation.

U Henning1, W P Wolf, M Holtzhauer.   

Abstract

Primary cardiac cell cultures of newborn rats containing approximately 50% (by cell number) spontaneously contracting cardiomyocytes were used to study the role of protein N-glycosylation for the binding of dihydropyridine (DHP) to the voltage-dependent L-type calcium channel. This binding is not influenced by the accompanying non-muscle cells. Exposure of the cells up to 6 micrograms/ml of the N-glycosylation inhibitor tunicamycin for a 44 h period resulted in a decrease of the specific DHP binding sites (Bmax) to 46.0 +/- 17.2% of the untreated control. Similar effects were observed after enzymatic deglycosylation using N-glycosidase F (PNGase F). The results suggest that a posttranslational modification of parts of the cardiac L-type Ca+2 channel by N-glycosylation is an important determinant for the binding of Ca+2 antagonists of the DHP-type to the alpha 1 subunit which itself is not glycosylated. The results suggest a participation of N glycosylation in the assembling of the subunits to the functional channel and/or its turnover. However, a possible effect of tunicamycin on the expression of the Ca channel as an alternative mechanism cannot be excluded.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8901453     DOI: 10.1007/bf00240029

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  19 in total

Review 1.  Receptor sites for Ca2+ channel antagonists.

Authors:  W A Catterall; J Striessnig
Journal:  Trends Pharmacol Sci       Date:  1992-06       Impact factor: 14.819

2.  Mast cells detected in cultures of neonatal rat heart cells.

Authors:  R Morwinski; U Karsten; G Wallukat
Journal:  Agents Actions       Date:  1994-06

3.  Ion channels: structure and function.

Authors:  J H Lawrence; G F Tomaselli; E Marban
Journal:  Heart Dis Stroke       Date:  1993 Jan-Feb

4.  Mutational analysis of beta-adrenergic receptor glycosylation.

Authors:  E Rands; M R Candelore; A H Cheung; W S Hill; C D Strader; R A Dixon
Journal:  J Biol Chem       Date:  1990-06-25       Impact factor: 5.157

5.  The roles of the subunits in the function of the calcium channel.

Authors:  D Singer; M Biel; I Lotan; V Flockerzi; F Hofmann; N Dascal
Journal:  Science       Date:  1991-09-27       Impact factor: 47.728

6.  Structural characterization of the dihydropyridine-sensitive calcium channel alpha 2-subunit and the associated delta peptides.

Authors:  S D Jay; A H Sharp; S D Kahl; T S Vedvick; M M Harpold; K P Campbell
Journal:  J Biol Chem       Date:  1991-02-15       Impact factor: 5.157

7.  Supersensitivity to beta-adrenoceptor stimulation evoked in cultured neonatal rat heart myocytes by L(+)-lactate and pyruvate.

Authors:  G Wallukat; A Wollenberger
Journal:  J Auton Pharmacol       Date:  1993-02

8.  Subunit-dependent modulation of recombinant L-type calcium channels. Molecular basis for dihydropyridine tissue selectivity.

Authors:  A Welling; Y W Kwan; E Bosse; V Flockerzi; F Hofmann; R S Kass
Journal:  Circ Res       Date:  1993-11       Impact factor: 17.367

Review 9.  Glycosidase inhibitors: inhibitors of N-linked oligosaccharide processing.

Authors:  A D Elbein
Journal:  FASEB J       Date:  1991-12       Impact factor: 5.191

10.  Subcellular distribution of the 1,4-dihydropyridine receptor in rabbit skeletal muscle in situ: an immunofluorescence and immunocolloidal gold-labeling study.

Authors:  A O Jorgensen; A C Shen; W Arnold; A T Leung; K P Campbell
Journal:  J Cell Biol       Date:  1989-07       Impact factor: 10.539

View more
  1 in total

1.  Characterization of membrane N-glycan binding sites of lysozyme for cardiac depression in sepsis.

Authors:  Hans Jacobs; Steven N Mink; Krika Duke; Deepak Bose; Zhao-Qin Cheng; Susan Howlett; Gregory R Ferrier; R Bruce Light
Journal:  Intensive Care Med       Date:  2004-12-17       Impact factor: 17.440

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.